Abarceo
Abarceo Pharma has identified a novel diabetes target located on beta cells and a novel mechanism of action enabling a therapeutic.
Business Model:
Revenue: $0
Employees: 2-10
Rankings
Industries / Tags:
Detailed Abarceo Information
Geographic Data
Address: Per Albin Hanssons vag 41
City: Malmo
State: skåne län
Zip: 205 12
Country: SE
Financial Info
Stage:
series unknown
Raised Last:
$3M
Raised Total:$3M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Abarceo Pharma is a spin out of Lund University Diabetes Center and is located in Malmo Sweden. Scientific founders Prof. Claes Wollheim, MD and Associate Prof. Albert Salehi are world-class experts in beta cell biology. Abarceo Pharma is a Lund University Holding company and was founded in December 2017. The company is dedicated to developing novel therapeutics for type-2 diabetes based upon a deep molecular and genetic understanding of the disease.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2021 | Venture Round | 1 | $2.6M |
Almi Invest Almi Invest |
9/2020 | Venture Round | 1 | - |
LU Holding LU Holding |
9/2020 | Venture Round | 1 | - |
LU Holding LU Holding |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
